Back
ESC Premium Access

Semaglutide consistently reduces cardiovascular risk in patients with type 2 diabetes regardless of baseline cardiovascular risk level: post hoc analyses of the SUSTAIN trial programme

Session: Poster Session 3 - Cardiac patients with comorbidities
Topic: Antidiabetic Pharmacotherapy
Speaker: Professor S. Bain (Swansea, GB)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Professor Stephen Bain

Swansea University, Swansea (United Kingdom of Great Britain & Northern Ireland)
2 presentations
0 follower

5 more presentations in this session

Increase in pulse rate with semaglutide did not result in increased adverse cardiac events in subjects with type 2 diabetes in the SUSTAIN 6 cardiovascular outcomes trial

Speaker: Professor J. Seufert (Freiburg, DE)

Access
Abstract
Slides
Like
Thumbnail

Liraglutide reduces cardiovascular events and mortality in type 2 diabetes independent of LDL cholesterol and statin use: results of the LEADER trial

Speaker: Professor S. Verma (Toronto, CA)

Access
Abstract
Slides
Like
Thumbnail

MRI evaluation of the impact of metformin and dapagloflizin on epicardial adipose tissue area in prediabetes and type 2 diabetes patients

Speaker: Professor C. Lang (Dundee, GB)

Access
Abstract
Like
Thumbnail

A systematic review and meta-analysis of anti-cytokine therapies targeting IL-1 and TNF- A in myocardial infarction and heart failure

Speaker: Ms M. Panahi (London, GB)

Access
Abstract
Slides
Like
Thumbnail

Additional therapy with nicorandil and quality of life in patients with stable coronary heart disease: a multicenter observational study

Speaker: Professor S. Martsevich (Moscow, RU)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 3 - Cardiac patients with comorbidities

Speakers: Professor S. Bain, Professor J. Seufert, Professor S. Verma, Professor C. Lang, Ms M. Panahi...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources